Inflammatory bowel disease (IBD) is an intestinal inflammatory condition that affects more
than 2 million people in the United States. Although the etiology and pathogenesis of IBD …

Microbe–host communication is essential to maintain vital functions of a healthy host, and its
disruption has been associated with several diseases, including Crohn's disease and …

Microbial dysbiosis characterized by alterations in the structure and function of the gut
microbiome has long been implicated in the pathogenesis of inflammatory bowel disease …

Inflammatory bowel diseases (IBDs) are chronic diseases of unclear etiology that affect over
1 million individuals in the United States and over 2.5 million people in Europe. However …

A vast community of commensal microorganisms, commonly referred to as the gut
microbiota, colonizes the gastrointestinal tract (GI). The involvement of the gut microbiota in …

The intestinal microbiota encompasses hundreds of bacterial species that constitute a
relatively stable ecosystem. Alteration in the microbiota composition may arise from …

Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is a
chronic and relapsing inflammatory disorder of the intestine. Although its incidence is …

A general consensus exists that IBD is associated with compositional and metabolic
changes in the intestinal microbiota (dysbiosis). However, a direct causal relationship …

Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative
colitis (UC), has emerged as a global disease with high incidence, long duration …

The human intestinal microbiome plays a critical role in human health and disease,
including the pathogenesis of inflammatory bowel disease (IBD). Numerous studies have …